Seamus Mulligan Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

JAZZ Quotes by TradingView

Seamus Mulligan is Director of Jazz Pharmaceuticals plc. Currently has a direct ownership of 1.18 Million shares of JAZZ, which is worth approximately $140 Million. The most recent transaction as insider was on Aug 02, 2024, when has been sold 3,731 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.18M
0% 3M change
0.32% 12M change
Total Value Held $140 Million

Seamus Mulligan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 02 2024
BUY
Grant, award, or other acquisition
-
3,731 Added 0.32%
1,176,106 Ordinary Shares
Aug 11 2023
BUY
Grant, award, or other acquisition
-
3,075 Added 0.26%
1,172,375 Ordinary Shares
Jun 08 2023
BUY
Exercise of conversion of derivative security
$367,920 $81.76 p/Share
4,500 Added 0.38%
1,169,300 Ordinary Shares
Mar 04 2023
BUY
Exercise of conversion of derivative security
$266,085 $59.13 p/Share
4,500 Added 0.38%
1,164,800 Ordinary Shares
Aug 05 2022
BUY
Grant, award, or other acquisition
-
2,561 Added 0.22%
1,160,300 Ordinary Shares
Jul 29 2021
BUY
Grant, award, or other acquisition
-
2,246 Added 0.19%
1,157,739 Ordinary Shares
SM

Seamus Mulligan

Director
Dublin 4, L2

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JAZZ